Experiences
Nuceiva▼ (Botulinum Toxin Type A) is indicated for the temporary improvement in the appearance of moderate to severe vertical lines between the eyebrows seen at maximum frown (glabellar lines), when the severity of the above facial lines has an important psychological impact in adults below 65 years of age. Prescribing information can be found at the end of this page1
SOO YOUN
at maximum frown
Soo Youn received a consultation with a healthcare professional prior to their Nuceiva treatment. Their HCP found them suitable for treatment. On October 3rd 2022, Soo Youn was treated with 20 units of Nuceiva across five injection sites: 2 injections in each corrugator muscle 1 injection in the procerus muscle Soo Youn was photographed at maximum frown before treatment (day 0) and on days 2, 30 and 120.
Individual results may vary
ARIELLE
at maximum frown
Arielle received a consultation with a healthcare professional prior to their Nuceiva treatment. Their HCP found them suitable for treatment. On October 3rd 2022, Arielle was treated with 20 units of Nuceiva across five injection sites: 2 injections in each corrugator muscle 1 injection in the procerus muscle Arielle was photographed at maximum frown before treatment (day 0) and on days 2, 30 and 120.
Individual results may vary
Sign up for more
like this
Here's what you'll see:
- Uncover detailed anatomy with our 5 glabella types course
- Understand safety and efficacy of Nuceiva
- Enroll for growth courses designed to help you ignite your practice
- Schedule meetings with the Evolus MSL or MCM
References
1. Nuceiva SmPC
ADVERSE EVENTS SHOULD BE REPORTED.
Reporting forms and information can be found at yellowcard.mhra.gov.uk/ or search MHRA yellow card in the Google Play or Apple App Store.
Adverse events should also be reported to Evolus International Ltd.
Please contact Evolus Europe Medical Information by medicalinformation@evolus.com or calling 08000541302.